Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease.
Phase of Trial: Phase II
Latest Information Update: 17 May 2017
At a glance
- Drugs Topiramate (Primary) ; Amantadine
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Therapeutic Use
- 30 Oct 2009 Actual initiation date (Sep 2009) added as reported by ClinicalTrials.gov.
- 30 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2009 Planned initiation date changed from 1 Dec 2008 to 1 Jul 2009 as reported by ClinicalTrials.gov.